Cargando…
Efficacy of mirabegron, a β(3)‐adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post‐hoc analysis of pooled data from two randomized, placebo‐controlled, double‐blind studies
OBJECTIVE: To confirm if mirabegron 50 mg shows efficacy in women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence versus placebo. METHODS: Post‐hoc analyses were carried out using pooled data from a Japanese phase IIb and a phase III study. The primary e...
Autores principales: | Takahashi, Satoru, Mishima, Yuji, Kuroishi, Kentaro, Ukai, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293404/ https://www.ncbi.nlm.nih.gov/pubmed/34605079 http://dx.doi.org/10.1111/iju.14700 |
Ejemplares similares
-
Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
por: Lee, Raymond T, et al.
Publicado: (2013) -
Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study
por: Yoshida, Masaki, et al.
Publicado: (2020) -
Mirabegron – a selective β3-adrenoreceptor agonist for the treatment of overactive bladder
por: Bhide, Alka A, et al.
Publicado: (2012) -
Urgency and urgency incontinence following stress urinary incontinence surgery: A review of evaluation and management
por: Gomelsky, Alex, et al.
Publicado: (2022) -
Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence
por: Wyman, J F, et al.
Publicado: (2009)